Zomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA Reach

Zomedica Corp. (NYSE:ZOM) shares are trading higher on Thursday. The company disclosed the expansion of its distribution partnership with Grovet.

The updated agreement grants Grovet exclusive equine distribution rights for Zomedica’s PulseVet and TRUFORMA product platforms across 27 countries in Europe.

The updated agreement gives Grovet exclusive rights to distribute Zomedica’s PulseVet and TRUFORMA equine products in 27 European countries, including Germany, France, and Spain. Distribution in Italy and ...

Full story available on Benzinga.com